(Q34182199)

31 July 2017

1 reference

title

Clarithromycin for Helicobacter pylori infection (English)

1 reference

Helicobacter pylori infectious disease

31 July 2017

0 references

1 reference

1 reference

2

Graham DY

1 reference

31 July 2017

Leung WK

1

1 reference

PubMed ID

11249534

31 July 2017

language of work or name

English

0 references

publication date

1 March 2000

1 reference

Expert Opinion on Pharmacotherapy

31 July 2017

1 reference

31 July 2017

1

1 reference

31 July 2017

507-514

1 reference

31 July 2017

3

1 reference

Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration

31 July 2017

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.3.507

Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.3.507

Helicobacter pylori infection induces gastric cancer in mongolian gerbils

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.3.507

Antibiotic resistance in Helicobacter pylori: implications for therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.3.507

Treatment failure of ofloxacin in Campylobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.3.507

Prevention of nitroimidazole resistance in Campylobacter pylori by coadministration of colloidal bismuth subcitrate: clinical and in vitro studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.3.507

Eradication of Helicobacter pylori with clarithromycin and omeprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.3.507

Eradication of Helicobacter pylori: an objective assessment of current therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.3.507

The importance of clarithromycin dose in the management of Helicobacter pylori infection: a meta-analysis of triple therapies with a proton pump inhibitor, clarithromycin and amoxycillin or metronidazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.3.507

One-week ranitidine bismuth citrate in combinations with metronidazole, amoxycillin and clarithromycin in the treatment of Helicobacter pylori infection: the RBC-MACH study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.3.507

Ranitidine bismuth citrate, tetracycline, clarithromycin twice-a-day triple therapy for clarithromycin susceptible Helicobacter pylori infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.3.507

Identification of a 23S rRNA gene mutation in clarithromycin-resistant Helicobacter pylori.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.3.507

Low rate of emergence of clarithromycin-resistant Helicobacter pylori with amoxycillin co-therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.3.507

Low- versus high-dose azithromycin triple therapy for Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.3.507

Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.3.507

The influence of in vitro nitroimidazole resistance on the efficacy of nitroimidazole-containing anti-Helicobacter pylori regimens: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.3.507

21 January 2018

Identifiers

DOI

10.1517/14656566.1.3.507

1 reference

31 July 2017

1 reference

PubMed ID

11249534